looking at peers such as 4DX ($600 mil ) and EMV ( $220 mil) . One has FDA approval but no contracts yet. Other one is in phase 1 trials . Nico with 8-15 hospitals in Europe and FDA / CE/ TGA approvals should be worth north of a minimum of $100 mil. Nearest peer to benchmark in AI stroke care is Viz AI. They got their FDA approval in 2018/2018 and post that they were able to get into the US rebate program for stroke diagnostics , similar to Nico. That company by my rough calcs is easily worth around $800 mil. blue sky from here . Lots of catalysts over next 12 months .
- Forums
- IPOs
- Nico.lab Pre IPO
Nico.lab Pre IPO, page-245
- There are more pages in this discussion • 441 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online